BRCA1/2 mutations have been identified in familial pancreatic cancers, with the majority being germline BRCA2 gene mutations, which occur in approximately 5–17% of patients with familial pancreatic cancer (Rawla et al., 2019). This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.